TAZ is a transcriptional coactivator upregulated in different types of cancer; its overexpression stimulates the expression of genes involved in NHEJ, such as TP53BP1 (53BP1), PRKDC (DNA-PKCs), and XRCC6 (Ku70), contributing to the radioresistant phenotype. The gene discussed is XRCC6; the disease is cancer.